Mask bans are dumb, dangerous | Editorial "What if a troublemaker simply decides to disguise his face with large sunglasses and a hat, instead? Are we going to criminalize sunglasses and hats, too? 1/ nj.com/opinion/2024/0…

Miksi riskiryhmien rokottamisen infektioturvallisuutta ei ole taaskaan mietitty? Haavoittuvin väki samassa paikassa ja jälleen korkea infektioesiintyvyys menossa. Viimeksi moni kuvasi saaneensa tartunnan näissä jonoissa. Eikö viime vuodesta opittu mitään? Sosiaali- ja terveyspalvelut Helsinki

And, yet, people continue to pay their salaries. Disappointingly many infection epidemiologists appear, indeed, to have chosen the side of the virus. The environmental epidemiologists that I have known and worked with world wide, however, understand from research the natural

So here we are today, with several variant-driven waves of infection/yr, at unpredictable intervals. The virus is evolving faster than ever before, and vaccines aren't slowing its evolution. We haven't reached the endemic state (see screenshots). It's a volatile situation. (11/

Tähän mennessä on selvinnyt, että Covidia vastaan ei muodostu laumasuojaa sen enempää tartuntojen kuin nykyisten kaltaisten rokotteidenkaan avulla. Sekä tartunnan että rokotteen antaman immuniteetin nopea hiipuminen että varianttispesifisyys tekevät laumasuojan mahdottomaksi.

Two papers. On the left, a non-randomized, non-crossover study showing that a one-off sauna exposure significantly decreased arterial stiffness, with implications on cardiovascular health. On the right, a randomized, crossover (more robust) study, showing no benefits on

Aortic stenosis - the most common heart valve disease - linked to insulin resistance in a new study 💗 Data from over 10,000 people🧑‍🤝‍🧑 New link could open doors for new treatment ⬇️ tandfonline.com/doi/full/10.10…

*** NEW *** Extensive combination of NMR lipoprotein and LC-MS/MS lipidomics data. Please be aware of lipoprotein mediation and its effects on epi (& genetic) analyses and interpretations; high likelihood for bias: academic.oup.com/aje/advance-ar… Siyu4869 Terho Lehtimäki Olli Raitakari

Today the newspapers are full of claims that dark chocolate reduces Type 2 diabetes. But before you stock up those festive treats, beware! george davey smith warns that this is just another example of "Today’s random medical news". ieureka.blogs.bristol.ac.uk/2024/12/04/dar…

What if everyone had masked up? "if everyone in the United Kingdom had worn N95 or FFP2 masks — both highly effective at filtering particles — the rate of COVID-19 transmission would have dropped by a factor of 9" nature.com/articles/d4158…

I first used this cartoon ~30 years ago, because of nonsense dietary epidemiology; remarkably the same cohort studies continue to yield such even though RCTs have so often shown their findings to be meaningless. Dark chocolate the last of such; a blog here ieureka.blogs.bristol.ac.uk/2024/12/04/dar…

Matias Turkkila Richard Dawkins Luottamus tieteeseen voidaan kyllä palauttaa, se vaatii vain intersektionaalisuuden purkua instituutioiden rakenteista 🧸👍

Do you remember when you joined X? I do! #MyXAnniversary

🫀 Our new study is published in #EHJ 📣 Measuring both #apoB and #LipoproteinA provides the most accurate assessment of cardiovascular risk in primary prevention doi.org/10.1093/eurhea… TIMI Study Group Chalmers University of Technology EHJ Editor-in-Chief European Society of Cardiology

New genetic analysis in 200k people over 14 years ▶️apoB + lp(a) best capture lipid-mediated CV risk ▶️LDL particle size adds no additional info when apoB is accounted for academic.oup.com/eurheartj/adva…

Deeper lipoprotein particle phenotyping enables more accurate cardiovascular risk assessment🫀 According to an analysis of NMR-based lipoprotein profiling in 200K UK Biobank participants, lipid-related cardiovascular risk is better captured by ApoB particle count & Lp(a).

From total cholesterol to LDL, HDL, and triglycerides, and now to ApoB and Lp(a), the evolution of lipid-related risk assessment reflects advances in lipoprotein phenotyping. A really nice read and a very comprehensive analysis. 🔗academic.oup.com/eurheartj/adva…

This paper is so important and puts to rest those jumping on the VLDL/remnant bandwagon at the expense of ignoring LDLs. What everyone needs to do is order apoB, a one-time Lp(a) and then work hard at lowering apoB. The treatments that lower apoB lower both remnant-P and LDL-P

What an amazing editorial by Sniderman et al - sadly firewalled - "Incorporating apoB and Lp(a) into routine clinical care will improve assessment of CV risk due to the apoB lipoproteins. Adopting apoB as the primary measure of the effectiveness of therapy will radically